Ras effector proteins

Ras effector proteins are a heterogeneous group of signaling molecules that selectively interact with the active, GTP-bound state of Ras small GTPases (UniProt, 2023). Upon binding to the Ras-effector domain, these proteins initiate a variety of downstream signaling cascades, most notably the Raf-MEK-ERK (MAPK) pathway and the PI3K-AKT-mTOR pathway (PubMed, PMID: 22589242). These pathways are fundamental regulators of cell proliferation, survival, and metabolic activity (StatPearls, 2023). In many human cancers, mutations in Ras or the effectors themselves lead to chronic, ligand-independent signaling that drives tumor growth and metastasis (NCI, 2022). Because of their central role in oncogenesis, Ras effectors like BRAF and MEK have become successful targets for small-molecule inhibitors, although therapeutic challenges such as rapid development of drug resistance and feedback loop activation remain significant hurdles (Nature Reviews Drug Discovery, 2020).

Other names

Ras-binding proteinsRas-interacting proteinsRas-responsive proteinsRas-effector molecules

Inhibition of downstream signaling cascades initiated by Ras activation, primarily the MAPK/ERK and PI3K/AKT/mTOR pathways, to suppress oncogenic cell growth and survival (PubMed, PMID: 30635031).